By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tonix Pharmaceuticals, Inc. 

509 Madison Ave.
Suite 306
New York  New York  10022  U.S.A.
Phone: 212-980-9155 Fax: 212-923-5700




Company News
Tonix Pharma (TNXP) To Present At Rodman & Renshaw18th Annual Global Investment Conference 9/7/2016 9:00:58 AM
Tonix Pharma (TNXP) to Stop Testing Lead Pain Drug, Stock Craters 9/6/2016 8:14:09 AM
Tonix Pharma (TNXP) Announces Successful End-Of-Phase II Meeting With FDA For TNX-102 SL In Post-Traumatic Stress Disorder 8/29/2016 8:17:59 AM
Tonix Pharma (TNXP) Presents Poster On The Development Of TNX-102 SL For Post-Traumatic Stress Disorder (PTSD) At The 2016 Military Health System Research Symposium 8/15/2016 9:30:16 AM
Tonix Pharma (TNXP) Reports Second Quarter 2016 Financial Results And Provides Programs Update 8/8/2016 8:13:07 AM
Tonix Pharma (TNXP) Initiates Second Pivotal Phase III Clinical Study Of TNX-102 SL In Fibromyalgia 7/26/2016 7:43:02 AM
Tonix Pharma (TNXP) Announces Full Exercise And Closing Of Underwriters’ Over-Allotment Option 7/13/2016 8:34:38 AM
Tonix Pharma (TNXP) To Present At Cantor Fitzgerald’s 2nd Annual Healthcare Conference 7/8/2016 9:50:30 AM
Tonix Pharma (TNXP) Presents Pharmacokinetic Data On TNX-102 SL As A Potential Treatment For The Management Of Fibromyalgia And Treatment Of Post-Traumatic Stress Disorder At The ASCPT 2016 Annual Meeting 3/9/2016 8:00:11 AM
Tonix Pharma (TNXP) CEO Toured Midtown To Raise Cash 3/2/2016 8:11:40 AM